Quick Answer
BIODESIX INC reported Stockholders Equity of -$2.46 million for fiscal year 2025.
BIODESIX INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$2.46M | -111.8% |
| 2024 | $20.88M | +355.8% |
| 2023 | $4.58M | -77.8% |
| 2022 | $20.61M | +4.5% |
| 2021 | $19.73M | -52.1% |
| 2020 | $41.17M | +118.3% |
| 2019 | -$225.14M | -15.7% |
| 2018 | -$194.63M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.72M | -106.2% | -251.3% |
| June 30, 2025 | $1.14M | -96.9% | -89.7% |
| March 31, 2025 | $11.06M | +301.0% | -47.0% |
| December 31, 2024 | $20.88M | +355.8% | -25.1% |
| September 30, 2024 | $27.86M | +2026.5% | -23.2% |
| June 30, 2024 | $36.26M | +618.5% | +759.0% |
| March 31, 2024 | -$5.50M | -220.9% | -220.1% |
| December 31, 2023 | $4.58M | -77.8% | +416.7% |
- BIODESIX INC showed a decrease of -111.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, BIODESIX INC’s stockholders equity has grown by 98.7% (from -$194.63 million to -$2.46 million).
- The most recent figure is from BIODESIX INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: